Bio Path Holdings Inc logo

Bio Path Holdings Inc Share Price Today (NASDAQ: BPTH)

Bio Path Holdings Inc share price is $0 & ₹0.00 as on 20 Feb 2025 IST

▲

-0.18

(-100%)

Market is closed - opens 7 PM, 14 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 21 Feb 2025

View live Bio Path Holdings Inc share price in Dollar and Rupees. Guide to invest in Bio Path Holdings Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bio Path Holdings Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Bio Path Holdings Inc (BPTH) Key Statistics

in dollars & INR

Previous Close
$0.185
Open
$0.19
Market Capitalization
$1.2M
Today's Volume
$136.6K
Revenue TTM
$0.0
EBITDA
$-12.4M
Earnings Per Share (EPS)
$-8.34
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1159.74%

How to invest in Bio Path Holdings Inc Stock (BPTH) from India?

It is very easy for Indian residents to invest directly in Bio Path Holdings Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bio Path Holdings Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bio Path Holdings Inc or BPTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bio Path Holdings Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bio Path Holdings Inc shares which would translate to null fractional shares of Bio Path Holdings Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Bio Path Holdings Inc, in just a few clicks!

Global Institutional Holdings in Bio Path Holdings Inc

  • Apollon Wealth Management, LLC

    0.26%

  • Geode Capital Management, LLC

    0.24%

  • Vanguard Group Inc

    0.23%

  • Citadel Advisors Llc

    0.19%

  • Tower Research Capital LLC

    0.06%

  • UBS Group AG

    0.05%

Analyst Recommendation on Bio Path Holdings Inc

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Bio Path Holdings Inc(by analysts ranked 0 to 5 stars)

About Bio Path Holdings Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.
Organization
Bio Path Holdings Inc
Employees
10
CEO
Mr. Peter H. Nielsen MBA
Industry
Health Technology

Management People of Bio Path Holdings Inc

NameTitle
Mr. Peter H. Nielsen MBA
Co-Founder, Chairman of the Board, CEO, President, CFO & Treasurer
Mr. Douglas P. Morris
Co-Founder, Director of Investor Relations, Secretary & Director
Mr. Michael Hickey M.B.A.
VP of Clinical Operations
Mr. Anthony Price MBA
Senior Vice President of Finance, Accounting & Administration
Dr. Ana Tari Ashizawa M.B.A., MBA, Ph.D.
Senior Vice President of Research, Development & Clinical Design

Important FAQs about investing in BPTH Stock from India :

Can Indians buy Bio Path Holdings Inc shares?

Yes, Indians can invest in the Bio Path Holdings Inc (BPTH) from India.

With INDmoney, you can buy Bio Path Holdings Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bio Path Holdings Inc at zero transaction cost.

How can I buy Bio Path Holdings Inc shares from India?

It is very easy to buy Bio Path Holdings Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bio Path Holdings Inc (BPTH) be purchased?

Yes, you can buy fractional shares of Bio Path Holdings Inc with INDmoney app.

What are the documents required to start investing in Bio Path Holdings Inc stocks?

To start investing in Bio Path Holdings Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Bio Path Holdings Inc?

Today's market capitalisation of Bio Path Holdings Inc BPTH is 1.2M

Who is the Chief Executive Officer (CEO) of Bio Path Holdings Inc ?

Mr. Peter H. Nielsen MBA is the current Chief Executive Officer (CEO) of Bio Path Holdings Inc.